Ronald E. Blaylock - Apr 28, 2022 Form 4 Insider Report for PFIZER INC (PFE)

Role
Director
Signature
Susan E. Grant, by power of atty., for Ronald E. Blaylock
Stock symbol
PFE
Transactions as of
Apr 28, 2022
Transactions value $
$205,000
Form type
4
Date filed
4/29/2022, 04:14 PM
Previous filing
Jul 20, 2021
Next filing
May 27, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Phantom Stock Units Award $205K +4.06K +10.92% $50.51 41.2K Apr 28, 2022 Common Stock 4.06K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each unit represents one phantom share of common stock.
F2 Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.
F3 These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.